Osteoporosis Management in the Era of COVID-19

  • Elaine W Yu
    Endocrine Unit Massachusetts General Hospital/Harvard Medical School Boston MA USA
  • Elena Tsourdi
    Center for Healthy Aging Universitätsklinikum Dresden Dresden Germany
  • Bart L Clarke
    Division of Endocrinology, Diabetes, Metabolism, and Nutrition Mayo Clinic Rochester MN USA
  • Douglas C Bauer
    Department of Epidemiology and Biostatistics University of California, San Francisco San Francisco CA USA
  • Matthew T Drake
    Robert and Arlene Kogod Center on Aging Mayo Clinic Rochester MN USA

書誌事項

公開日
2020-05-14
権利情報
  • https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/jbmr.4049
公開者
Oxford University Press (OUP)

この論文をさがす

説明

<jats:title>ABSTRACT</jats:title> <jats:p>Osteoporosis is a chronic condition that reflects reduced bone strength and an associated increased risk for fracture. As a chronic condition, osteoporosis generally requires sustained medical intervention(s) to limit the risks for additional bone loss, compromise of skeletal integrity, and fracture occurrence. Further complicating this issue is the fact that the abrupt cessation of some therapies can be associated with an increased risk for harm. It is in this context that the COVID-19 pandemic has brought unprecedented disruption to the provision of health care globally, including near universal requirements for social distancing. In this Perspective, we provide evidence, where available, regarding the general care of patients with osteoporosis in the COVID-19 era and provide clinical recommendations based primarily on expert opinion when data are absent. Particular emphasis is placed on the transition from parenteral osteoporosis therapies. It is hoped that these recommendations can be used to safely guide care for patients with osteoporosis until a return to routine clinical care standards is available. © 2020 American Society for Bone and Mineral Research.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ